← SynDRA

NARINGENIN

SynDRA canonical compound SYN0000336 — structure-anchored drug synonym record

All known targets

• CYP19A1
• ESR2
• CYP1B1
• GLO1
• HSD17B1

Mechanisms of action (all sources)

• TRPV antagonist
• Aromatase inhibitor
• GLO1 INHIBITOR
• ESR2 INHIBITOR
• CYP1B1 INHIBITOR
• CYP19A1 INHIBITOR
• HSD17B1 INHIBITOR

Drug classes

• Anti-Ulcer Agents
• Estrogen Antagonists

Cross-references

• PubChem CID: 439246
• ChEMBL: CHEMBL9352
• DrugBank: DB03467
• ChEBI: 50202
• KEGG: C00509
• PDB: NAR
• Wikipedia: Naringenin
• TTD: D02ABO
• LINCS BRD: BRD-K08832567

Synonyms

• 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
• 4',5,7-Trihydroxyflavanone
• Naringenine
• (+/-)-Naringenin
• naringetol
• salipurpol
• (-)-Naringenin
• NARIGENIN
• Salipurol
• 5,7,4'-Trihydroxyflavanone
• (S)-Naringenin
• BE-14348A
• NSC-34875
• ( inverted exclamation markA)-Naringenin
• CHEMBL32571
• MLS000738094
• MLS000028739
• CHEBI:50202
• Flavanone, 4',5,7-trihydroxy-
• FTVWIRXFELQLPI-UHFFFAOYSA-N
• NSC34875
• NSC11855
• MFCD00006844
• SMR000059039
• AK122638
• NSC-11855
• 4',7-Trihydroxyflavanone
• YSO1
• (-)-(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
• (-)-(2S)-Naringenin
• (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one
• (2S)-4',5,7-trihydroxyflavan-4-one
• (2S)-4',5,7-trihydroxyflavanone
• (2S)-5,7,4'-trihydroxyflavone
• (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one
• (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
• (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one
• (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one